B. Manger

878 total citations
20 papers, 523 citations indexed

About

B. Manger is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Manger has authored 20 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in B. Manger's work include Rheumatoid Arthritis Research and Therapies (8 papers), Urticaria and Related Conditions (3 papers) and Vasculitis and related conditions (3 papers). B. Manger is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Urticaria and Related Conditions (3 papers) and Vasculitis and related conditions (3 papers). B. Manger collaborates with scholars based in Germany, United States and Netherlands. B. Manger's co-authors include Georg Schett, Christian Antoni, Arthur Kavanaugh, Ricky W. Johnstone, Peter C. Taylor, Sergio Schwartzman, Juan J. Gómez‐Reino, Frederick Wolfe, Jörg H. W. Distler and Jürgen Rech and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Journal of Molecular Medicine.

In The Last Decade

B. Manger

19 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Manger Germany 10 350 109 109 87 66 20 523
Hiroyuki Nara Japan 9 305 0.9× 91 0.8× 115 1.1× 69 0.8× 158 2.4× 23 519
Dèlia Reina Spain 11 238 0.7× 64 0.6× 75 0.7× 63 0.7× 84 1.3× 53 427
Daniela Opriș-Belinski Romania 11 288 0.8× 48 0.4× 49 0.4× 45 0.5× 150 2.3× 89 557
Béatrice Molena Italy 12 186 0.5× 200 1.8× 71 0.7× 57 0.7× 134 2.0× 28 497
Toshio Odani Japan 12 149 0.4× 127 1.2× 47 0.4× 78 0.9× 92 1.4× 18 468
Rossella Franceschini Italy 20 504 1.4× 259 2.4× 145 1.3× 46 0.5× 75 1.1× 48 1.1k
Ritva Peltomaa Finland 13 345 1.0× 30 0.3× 122 1.1× 33 0.4× 93 1.4× 27 571
Philip Murphy Ireland 13 95 0.3× 50 0.5× 203 1.9× 64 0.7× 53 0.8× 54 533
D. Lium United States 5 270 0.8× 63 0.6× 171 1.6× 32 0.4× 136 2.1× 7 596
Antonio G. Tristano Venezuela 11 203 0.6× 23 0.2× 73 0.7× 43 0.5× 65 1.0× 25 454

Countries citing papers authored by B. Manger

Since Specialization
Citations

This map shows the geographic impact of B. Manger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Manger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Manger more than expected).

Fields of papers citing papers by B. Manger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Manger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Manger. The network helps show where B. Manger may publish in the future.

Co-authorship network of co-authors of B. Manger

This figure shows the co-authorship network connecting the top 25 collaborators of B. Manger. A scholar is included among the top collaborators of B. Manger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Manger. B. Manger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valor, L., Arnd Kleyer, Georg Schett, B. Manger, & Michael Sticherling. (2021). Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis. Lara D. Veeken. 60(9). e312–e313.
2.
Hagen, Melanie, et al.. (2020). Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Lara D. Veeken. 60(1). 479–480. 36 indexed citations
3.
Meißner, Yvette, Martin Schäfer, B. Manger, et al.. (2018). THU0142 The prognosis of heart failure in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 77. 291–292. 1 indexed citations
4.
Strangfeld, Anja, Adrian Richter, B. Manger, et al.. (2017). FRI0130 Rates and risk factors of new-onset psoriasis under different biologic agents and conventional synthetic dmard treatment. Annals of the Rheumatic Diseases. 76. 530–530. 2 indexed citations
5.
Strangfeld, Anja, et al.. (2015). OP0017 Pregnancies in Patients with Rheumatoid Arthritis: Treatment Decisions, Course of the Disease, and Pregnancy Outcomes. Annals of the Rheumatic Diseases. 74. 70–71. 3 indexed citations
6.
Vaglio, Augusto, Johanna Strehl, B. Manger, et al.. (2011). IgG4 immune response in Churg–Strauss syndrome. Annals of the Rheumatic Diseases. 71(3). 390–393. 123 indexed citations
7.
Schildmann, Jan, et al.. (2011). A Patient with Systemic Sclerosis and Chylothorax: Successful Treatment with Parenteral Nutrition and Octreotide. Aktuelle Rheumatologie. 36(3). 193–195. 1 indexed citations
8.
Cimaz, Rolando, Séverine Guillaume, Max J. Hilz, et al.. (2010). Awareness of Fabry disease among rheumatologists—current status and perspectives. Clinical Rheumatology. 30(4). 467–475. 11 indexed citations
9.
Grünke, Mathias, Christian Antoni, Arthur Kavanaugh, et al.. (2010). Standardization of Joint Examination Technique Leads to a Significant Decrease in Variability Among Different Examiners. The Journal of Rheumatology. 37(4). 860–864. 31 indexed citations
10.
Taylor, Peter C., B. Manger, Ricky W. Johnstone, et al.. (2010). Patient Perceptions concerning Pain Management in the Treatment of Rheumatoid Arthritis. Journal of International Medical Research. 38(4). 1213–1224. 132 indexed citations
11.
Manger, B., et al.. (2004). [Biologicals: a new therapeutic approach for inflammatory diseases].. Der Internist. 45 Suppl 1. S31–7. 1 indexed citations
12.
Antoni, Christian & B. Manger. (2003). Infliximab for psoriasis and psoriatic arthritis.. PubMed. 20(6 Suppl 28). S122–5. 31 indexed citations
13.
Kvien, T.K., H. Zeidler, Pekka Hannonen, et al.. (2002). Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Annals of the Rheumatic Diseases. 61(6). 511–516. 25 indexed citations
14.
Manger, B.. (2002). Überarbeitete Empfehlungen der Deutschen Gesellschaft fÜr Rheumatologie. Zeitschrift für Rheumatologie. 61(6). 694–697. 7 indexed citations
15.
Zeidler, H., T.K. Kvien, Pekka Hannonen, et al.. (1998). Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Lara D. Veeken. 37(8). 874–882. 51 indexed citations
16.
Neipel, Frank, Astrid Rascu, B. Manger, et al.. (1998). Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.. PubMed. 3(10). 461–4. 38 indexed citations
17.
Strobel, Gero, et al.. (1993). [Use of an improved transmission ultrasound camera for diagnosis of rheumatic joint diseases].. PubMed. 52(2). 114–20. 1 indexed citations
18.
Manger, B., et al.. (1991). The role of antineutrophil cytoplasm antibodies, anticardiolipin antibodies, von Willebrand factor antigen, and fibronectin for the diagnosis of systemic vasculitis.. PubMed. 18(8). 1199–206. 26 indexed citations
19.
Krapf, F., B. Manger, & J. R. Kalden. (1986). Immunkomplexe bei Allergien: Nachweis von IgE-haltigen Immunkomplexen bei der Vaskulitis Churg-Strauss. Journal of Molecular Medicine. 64(12). 563–569. 1 indexed citations
20.
Manger, B., et al.. (1985). Coexistence of severe palmo-plantar dupuytren's contracture, raynaud's phenomenon and digital joint erosions. Rheumatology International. 5(2). 95–96. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026